Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Alliance Pharma PLC - Chippenham, England-based distributor of consumer healthcare brands and prescription medicines - Says it acquires silicone-based scar treatment brand ScarAway from Perrigo Co PLC. Alliance Pharma also buys the rights to sell its scar treatment brand brand Kelo-cote in the US. Alliance Pharma pays $19.4 million in cash from existing financial resources to Dublin, Ireland-based Perrigo for both assets.
Current stock price: 114.80 pence, up 2.5% on Friday
12-month change: up 30%
Copyright 2022 Alliance News Limited. All Rights Reserved.